Intra-Patient Tumor Heterogeneity in Patients with Solid Tumors
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Scottsdale/Phoenix, Arizona: 16-001246
Sponsor Protocol Number: 16-001246
About this study
The purpose of this study is to identify clonal eveolation of tumors by genomically altered DNA sequences resulting from copy number alterations in tumors at initial diagnosis and on recurrence.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- Patients must have a diagnosis of a solid tumor
- Patients must have availability of tumor tissue from at least 2 separate areas either from a primary and metastatic lesion or two separate metastasis.
- ≥18 years of age
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Scottsdale/Phoenix, Ariz.
Mayo Clinic principal investigator Ramesh Ramanathan, M.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available